Investor

Also: Mercom's Q1 2020 digital health funding report; Fitbit, Scripps, Stanford collaborate on COVID-19 detection research.

Just as it's doing with nearly every facet of society around the world, the COVID-19 crisis will radically transform approaches with patient engagement and pop health. From telemedicine and remote patient monitoring to AI and advanced analytics, healthcare was already in the midst of big changes in how it manages the health of patient populations. Now, in a new era where the pandemic is upending old assumptions, the stakes are even higher. This month, we look at how approaches to treating COVID-19 and other illnesses are shifting in this new era.  

Many are anticipating greater adoption of digital health services and more favorable regulatory and reimbursement environments, according to a recent poll sampling 513 digital health and adjacent companies.

Also: Datos Health ties off $7 million in Series A funding; Wellthy Therapeutics collects $4 million in pre-Series A; Lifesprk fleshes out tech with $16.1 million.

Amid COVID-19, a new 1,000-person survey suggests high demand for remote health services.

The company plans to use the new funds to expand commercialization in the US, Europe and Israel. 

The Boston-headquartered company offers over 30 mental health support programs. 

Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital participated in this round. 

According to the new Rock Health funding report in Q1 digital health companies raised $3.1 billion in new investments. However, with the coronavirus hurting the economy, the rest of the year may not follow suit. 

The company will use the money to increase its European presence.